These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss, Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview, maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well. When asked about the benefits observed in patients using GLP-1RA medications for conditions other than diabetes, the top five areas of improvement that physicians reported included weight loss (92 percent), positive effects on lipid profiles (57 percent), reduced cravings or dependency behaviors (56 percent), reduced blood pressure (48 percent), and reduced inflammation (46 percent)
Every ranking you read, including any number quoted here, is cross-trial inference across different molecules, populations, endpoints, and trial durations
May 21, 2026
Therefore, it is possible to continuously generate a large amount of hydrogen in the large intestine, in which the environment is neutral to weakly alkaline, by oral administration of the Si-based agent